Britain is re‑examining its NHS deal with Palantir.
The Department of Health announced a formal review of the data‑analytics contract that links the NHS to Palantir's software platform. Officials say the review will assess performance, cost and compliance with privacy standards, and could lead to an early termination. The process is expected to run for several weeks while ministries gather internal reports and stakeholder feedback.
The outcome matters because the NHS handles millions of patient records, and any change could disrupt data pipelines used for scheduling, demand forecasting and pandemic monitoring. It also signals how tolerant governments remain of large US tech firms that have faced criticism over data usage.
If the contract ends, the NHS will need a replacement analytics solution, and other public bodies may rethink similar vendor relationships.
